Job Description

JOB OVERVIEW:

The Business Analyst & Project Management role specializes in analyzing, documenting, and facilitating the implementation of projects like Learning Management Systems (LMS), Electronic Forms Management (E-forms), Document Management Systems (DMS), E APQR, MES and Validation Learning Management Systems (VLMS). This role involves collaborating with stakeholders to gather and analyze requirements, translating business needs into technical specifications, and ensuring successful delivery and adoption of application solutions. This role also requires to lead and support digital transformation initiatives within the Piramal pharma Limited. This hybrid role is ideal for someone with strong analytical capabilities, project management expertise, and a passion for leveraging digital technologies to improve operational efficiency, and compliance.

KEY STAKEHOLDERS: INTERNAL

o Business - Site / Corporate functions
o IT Team (e.g. SAP/ Infra / Quality IT / Allied / SAP Basis/ CSV/ QeC)

KEY STAKEHOLDERS: EXTERNAL

o IT Vendors
o IT Contractors/Consultants

REPORTING STRUCTURE:

o Reporting Associate General Manager - QeC
o

QUALIFICATION:

o Graduate in Science/Pharmacy/Engineering
o Post Graduation - Science/MBA (Desirable)

EXPERIENCE:

o Candidate with 8 to 12 years of Program management experience in Pharma/Life science domain working on of Learning Management (LMS), E-Forms using LCNC platform, Document Management System (DMS), Validation Lifecycle Management System (VLMS), E-APQR, MES.
o Work experience in both IT Sector and Pharma Sector will be desirable.

SKILLS AND COMPETENCIES

o Act as a business analyst for implementation and lifecycle management for various Pharma GxP applications and ensure seamless integration with other site and enterprise applications.

In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth.
Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices.

Equal employment opportunity

Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics.



We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice.

Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business, and the India Consumer Healthcare business selling over-the-counter products.


PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies. PCC's complex hospital product portfolio includes inhalation anaesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anaesthetics, injectable anti-infectives, and other therapies. The Indian Consumer Healthcare business is among the leading players in India in the self-care space, with established brands in the Indian consumer healthcare market. In addition, PPL has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. In October 2020, the company received a growth equity investment from the Carlyle Group.